AMI> Vol.4 No.2, April 2014

New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
Weill Cornell Medical College, New York, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA
Weill Cornell Medical College, New York, USA
University of Cologne, Cologne, Germany
University of Washington, Seattle, USA
New York University School of Medicine, New York, USA
New York University School of Medicine, New York, USA

 

Copyright © 2014 John Murray, Wai H. Tsui, Yi Li, Pauline McHugh, Schantel Williams, Megan Cummings, Elizabeth Pirraglia, Lilja Solnes, Ricardo Osorio, Lidia Glodzik, Shankar Vallabhajosula, Alexander Drzezga, Satoshi Minoshima, Mony J. de Leon, Lisa Mosconi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Murray, J. , H. Tsui, W. , Li, Y. , McHugh, P. , Williams, S. , Cummings, M. , Pirraglia, E. , Solnes, L. , Osorio, R. , Glodzik, L. , Vallabhajosula, S. , Drzezga, A. , Minoshima, S. , J. de Leon, M. and Mosconi, L. (2014) FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease. Advances in Molecular Imaging, 4, 15-26. doi: 10.4236/ami.2014.42003.

 

Download citation as EndNote